Patterns, perceptions and their association with changes in alcohol consumption in cancer survivors.


Journal

European journal of cancer care
ISSN: 1365-2354
Titre abrégé: Eur J Cancer Care (Engl)
Pays: England
ID NLM: 9301979

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 28 08 2017
revised: 27 08 2018
accepted: 28 08 2018
pubmed: 17 10 2018
medline: 15 5 2019
entrez: 17 10 2018
Statut: ppublish

Résumé

Continued consumption of alcohol after a cancer diagnosis is associated with poorer outcomes. We evaluated whether perceptions of the effects of continued alcohol use and receiving information on moderating alcohol reduced alcohol consumption in adult cancer survivors. A total of 509 cancer survivors were cross-sectionally surveyed at follow-up for their alcohol use before and after cancer diagnosis and perceptions of continued drinking. Multivariable logistic regression models evaluated factors associated with changes in alcohol consumption after diagnosis. Among 299 patients who were drinking alcohol at diagnosis (13% exceeding gender-specific guidelines), 52% reduced/ceased alcohol consumption 1 year after diagnosis. Patients perceiving that alcohol worsened their own (a) quality of life, (b) cancer-related fatigue or (c) overall survival were more likely (aORs = 2.43-3.35, p < 0.002) to reduce (moderating or quitting) their alcohol use 1 year after diagnosis. Only 14% of individuals currently drinking regularly recalled receiving information/counselling from healthcare providers on alcohol consumption (7% from oncologists). However, there was a significant fourfold to sixfold increase in cessation with such information/counselling (p < 0.01). Similar trends were observed in patients exceeding gender-specific guidelines. Perception of negative effects of alcohol use on their health by cancer survivors was associated with reducing harmful alcohol consumption. Counselling, especially from the oncologist, may play a significant role for reducing consumption.

Identifiants

pubmed: 30324631
doi: 10.1111/ecc.12933
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e12933

Subventions

Organisme : Posluns Family Foundation
Organisme : Alan B Brown Chair in Molecular Genomics
Organisme : Cancer Care Ontario Chair in Experimental Therapeutics and Population Studies
Organisme : COMBIEL
Organisme : ONPROST

Informations de copyright

© 2018 John Wiley & Sons Ltd.

Auteurs

Lawson Eng (L)

Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Hospital/University Health Network and University of Toronto, Toronto, ON, Canada.
Ontario Cancer Institute, Toronto, ON, Canada.

Dan Pringle (D)

Ontario Cancer Institute, Toronto, ON, Canada.

Jie Su (J)

Ontario Cancer Institute, Toronto, ON, Canada.
Department of Biostatistics, Princess Margaret Hospital/University Health Network and University of Toronto, Toronto, ON, Canada.

Osvaldo Espin-Garcia (O)

Ontario Cancer Institute, Toronto, ON, Canada.
Department of Biostatistics, Princess Margaret Hospital/University Health Network and University of Toronto, Toronto, ON, Canada.

Chongya Niu (C)

Ontario Cancer Institute, Toronto, ON, Canada.

Mary Mahler (M)

Ontario Cancer Institute, Toronto, ON, Canada.

Oleksandr Halytskyy (O)

Ontario Cancer Institute, Toronto, ON, Canada.

Rebecca Charow (R)

Ontario Cancer Institute, Toronto, ON, Canada.

Christine Lam (C)

Ontario Cancer Institute, Toronto, ON, Canada.

Ravi M Shani (RM)

Ontario Cancer Institute, Toronto, ON, Canada.

Jodie Villeneuve (J)

Ontario Cancer Institute, Toronto, ON, Canada.

Kyoko Tiessen (K)

Ontario Cancer Institute, Toronto, ON, Canada.

Aditi Dobriyal (A)

Ontario Cancer Institute, Toronto, ON, Canada.

Aein Zarrin (A)

Ontario Cancer Institute, Toronto, ON, Canada.

Ashlee Vennettilli (A)

Ontario Cancer Institute, Toronto, ON, Canada.

M Catherine Brown (MC)

Ontario Cancer Institute, Toronto, ON, Canada.

Shabbir M H Alibhai (SMH)

Department of Medicine, University of Health Network, Toronto, ON, Canada.

Doris Howell (D)

Ontario Cancer Institute, Toronto, ON, Canada.

Jennifer M Jones (JM)

Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Hospital/University Health Network and University of Toronto, Toronto, ON, Canada.
Ontario Cancer Institute, Toronto, ON, Canada.
Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.

Peter Selby (P)

Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
Centre for Addiction and Mental Health, University of Toronto, Toronto, ON, Canada.
Departments of Family and Community Medicine & Psychiatry, University of Toronto, Toronto, ON, Canada.

Wei Xu (W)

Ontario Cancer Institute, Toronto, ON, Canada.
Department of Biostatistics, Princess Margaret Hospital/University Health Network and University of Toronto, Toronto, ON, Canada.
Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.

Geoffrey Liu (G)

Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Hospital/University Health Network and University of Toronto, Toronto, ON, Canada.
Ontario Cancer Institute, Toronto, ON, Canada.
Department of Biostatistics, Princess Margaret Hospital/University Health Network and University of Toronto, Toronto, ON, Canada.
Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH